Curaleaf Holdings (CURLF) Deferred Taxes (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Deferred Taxes of $81.6 million for Q4 2024, up 81.69% year-on-year from $44.9 million in Q1 2024, and up 821.1% on a QoQ basis from -$11.3 million in Q3 2024.
Curaleaf Holdings (CURLF) Deferred Taxes (2019 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Deferred Taxes for 6 consecutive years, with $81.6 million the latest figure, recorded in Q4 2024.
- Quarterly Deferred Taxes rose 81.69% year-over-year to $81.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $109.0 million (up 82.42% YoY) and the FY2025 annual result came in at $34.1 million, down 37.44% from the prior year.
- Deferred Taxes rose to $81.6 million in Q4 2024 per CURLF's latest filing, from -$11.3 million in the prior quarter.
- Over the last five years, Deferred Taxes for CURLF reached as high as $81.6 million in Q4 2024 and fell as low as -$12.6 million in Q3 2022.
- A 5-year average of $7.8 million and a median of -$1.7 million in 2021 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2020 — Deferred Taxes sank 306.84% — and 2022, when it soared 482.57%.
- Year by year, Deferred Taxes stood at -$6.0 million in 2020, then slumped by 45.12% to -$8.8 million in 2021, then surged by 482.57% to $33.6 million in 2022, then jumped by 33.7% to $44.9 million in 2023, then surged by 81.69% to $81.6 million in 2024.
- According to Business Quant data, Deferred Taxes over the past three periods registered $81.6 million, -$11.3 million, and $44.9 million for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 81.60 Mn |
| Sep 30, 2024 | -11.32 Mn |
| Dec 31, 2023 | 44.91 Mn |
| Sep 30, 2023 | -6.20 Mn |
| Dec 31, 2022 | 33.59 Mn |
| Sep 30, 2022 | -12.55 Mn |
| Jun 30, 2022 | -5.92 Mn |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | -8.78 Mn |
| Sep 30, 2021 | -10.07 Mn |
| Jun 30, 2021 | 11.69 Mn |
| Mar 31, 2021 | -3.44 Mn |
| Dec 31, 2020 | -6.05 Mn |
| Sep 30, 2020 | 11.27 Mn |
| Jun 30, 2020 | 4.57 Mn |
| Mar 31, 2020 | 1.94 Mn |
| Dec 31, 2019 | 2.93 Mn |